Testing effectiveness (Phase 2)WithdrawnNCT05480657
What this trial is testing
Safety, Tolerability, and Efficacy of Immunomodulation With AT-1501 in Combination With Transplanted Islet Cells in Adults With Brittle T1D
Who this might be right for
Brittle Type 1 Diabetes Mellitus
Eledon Pharmaceuticals